Applause For National Dementia Strategy From Actress June Brown MBE, UK
The Lewy Body Society heartily welcomes the publication of the Government's National Dementia Strategy , published last week, for which £150 million has been earmarked for dementia care over the next two years. Measures to be undertaken include the appointment of a senior clinician in every hospital and care home in England, who will be responsible for seeing that the needs of dementia sufferers are met.
Tuesday, February 10, 2009
Monday, February 9, 2009
PrandiMet(R), First Repaglinide And Metformin HCl Fixed Dose Combination Therapy, Now Available In The United States
PrandiMet(R), First Repaglinide And Metformin HCl Fixed Dose Combination Therapy, Now Available In The United States
Novo Nordisk and Sciele Pharma, Inc., a Shionogi Company, announced the availability of PrandiMet® (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the short-acting secretagogue repaglinide (also known as Prandin®) and insulin sensitizer metformin HCl for the treatment of type 2 diabetes in the United States.
Novo Nordisk and Sciele Pharma, Inc., a Shionogi Company, announced the availability of PrandiMet® (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the short-acting secretagogue repaglinide (also known as Prandin®) and insulin sensitizer metformin HCl for the treatment of type 2 diabetes in the United States.
Sunday, February 8, 2009
New Open-Source Software Permits Faster Desktop Computer Simulations Of Molecular Motion
Whether vibrating in place or taking part in protein folding to ensure cells function properly, molecules are never still. Simulating molecular motions provides researchers with information critical to designing vaccines and helps them decipher the bases of certain diseases, such as Alzheimer's and Parkinson's, that result from molecular motion gone awry. In the past, researchers needed either supercomputers or large computer clusters to run simulations. Continue reading ...
Subscribe to:
Posts (Atom)